In Spain, a competitive battle will be fought between models of one of the most revolutionary medical devices of recent times. The historic Da Vinci robotic system has come up with a competitor that will arrive in the country throughout this month of October thanks to Medtronic.
The Irish company has managed to obtain the CE marking for its Hugo system and will now seek to gain a foothold in a market of around 250 million euros in our country.
To date, Da Vinci (manufactured by the Californian company Intuitive Surgical) is the only device on the market. In Spain, the partner in charge is the company Abex, who explains that there are currently more than 80 robotic systems of this class installed, a number that is expected to reach 90 by the end of the year. “After the United States, where there are more than 3,000 Da Vinci robotic systems, Europe represents the main area of use with more than 900 robotic systems in activity. Spain, in this regard, is among the five markets in Europe with the highest number of Da Vinci surgical systems installed, behind France, Italy, England and Germany “, they explain from the company. The price of each of these robotic systems is between “two and three million euros,” they add.
Medtronic clarifies that the CE mark approval for their robot is for urological and gynecological procedures. According to Abex, in Spain and Portugal during 2020 more than 9,000 interventions with Da Vinci were carried out, which represents a growth of more than 10% compared to 2019. In addition, the two areas where it will compete with the Medtronic robot added 69% of last year’s interventions.
The technology company will introduce its Hugo technology at the HM Sanchinarro University Hospital. “With the system, we go from operating with a robot to total robotization of the operating room, which opens the door to address new specialties and pathologies,” says Juan Abarca, president of the hospital group. In addition, Medtronic says that “Hugo is designed to address the costs and utilization barriers that have limited the adoption of robotic surgery for two decades.”
The question of price of the systems as a barrier to penetration is something that also worries Abex with its Da Vinci. The company explains that it offers facilities in the payment of the systems as one of the ways to break down the implementation barriers and achieve equity in Spain. As detailed, in Extremadura there is still no Da Vinci, while in Galicia seven teams were bought this summer.
The story of ‘Hugo’
Before its arrival in Europe, Medtronic’s robotic system, Hugo, has already carried out tests in different parts of the world. In fact, the company acknowledges that CE mark approval comes on the heels of milestones in the global launch of the system, including the first urological and gynecological procedures, which were performed in Latin America and India and marked the start of global registration. of patients. Now it is the turn of Spanish hospitals to decide whether to buy this medical robot.